Immunet

Mercy BioAnalytics Adds Scientific, Quality, and Regulatory Leadership in Preparation for Clinical Development

Retrieved on: 
Thursday, March 23, 2023
Biotechnology, Pharmaceutical, Oncology, General Health, Health, Hospitals, Clinical Trials, Other Health, University, NGS, Roche, New product development, Holy Grail, Liquid biopsy, Cancer, Smith, Research, MDC, Doctor of Philosophy, Quality, Lung, Gordon, PMA, Immunet, Regulation, FDA, Conference, Nursing, Mercy, Medicine

Mercy BioAnalytics, Inc. , a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced that it has added two senior executives as the Company transitions from research to clinical development.

Key Points: 
  • Mercy BioAnalytics, Inc. , a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced that it has added two senior executives as the Company transitions from research to clinical development.
  • Toumy Guettouche, PhD has joined Mercy as the Chief Scientific Officer, and Michael Smith has joined as the company’s first Vice President for Quality, Regulatory, and Clinical Affairs.
  • Prior to his tenure at MDC, he held leadership roles in several diagnostics companies including ALPCO Diagnostics and Immunetics.
  • “Mercy’s commitment to quality, and to the design and execution of rigorous clinical studies, is a key differentiator.

Former RSA Chief Technology Officer Zulfikar Ramzan Joins Aura as Chief Scientist

Retrieved on: 
Thursday, January 20, 2022
Technology, RSA Security, Zulfiqar, Ramzan, Bluecoat, CEO, Massachusetts Institute of Technology, Leadership, History, Cisco Systems, Netwitness, Today, RSA, Doctor of Philosophy, Multimedia, Life, Board, Machine learning, Management, Cryptocurrency, Online shopping, Elastica, Immunet

BOSTON, Jan. 20, 2022 /PRNewswire/ -- Aura, a leading provider of proactive, all-in-one digital security for consumers, today announced the appointment of Dr. Zulfikar Ramzan to chief scientist and CEO of Aura Labs.

Key Points: 
  • BOSTON, Jan. 20, 2022 /PRNewswire/ -- Aura, a leading provider of proactive, all-in-one digital security for consumers, today announced the appointment of Dr. Zulfikar Ramzan to chief scientist and CEO of Aura Labs.
  • Ramzan joins Aura from RSA, where he served as chief technology officer and chief digital officer.
  • Ramzan joined RSA in 2015 as chief technology officer and for the past year has been RSA's chief digital officer.
  • Prior to his role with RSA, Ramzan served as chief technology officer of Elastica (acquired by Blue Coat), chief scientist of Sourcefire (acquired by Cisco), and chief scientist of Immunet (acquired by Sourcefire).Ramzan holds a PhD in electrical engineering and computer science from the Massachusetts Institute of Technology, where his doctoral advisor was Professor Ronald L. Rivest, co-founder of RSA Data Security.